While some research studies suggest that preoperative elevations of CA125 may aid in distinguishing leiomyomas from leiomyosarcomas, other studies underscore the biomarker’s restricted diagnostic reliability due to significant overlaps in values between benign and malignant conditions [3,58,59]. Here, MUC16 is linked to leiomyosarcoma.